rs1799983, NOS3

N. diseases: 246
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Further subgroup analyses yielded similar positive results for G894T SNP in essential hypertension, gestational hypertension, and Asian ethnicity, and that for T-786C SNP in essential hypertension and Asian population. 28287883 2017
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Impact of obesity and nitric oxide synthase gene G894T polymorphism on essential hypertension. 26579574 2015
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE We explored the associations of the G894T polymorphism with 24-h ambulatory blood pressure, left ventricular mass (LVM), carotid intima media thickness (cIMT), urinary albumin excretion, oxidative stress and inflammatory parameters in 126 children with newly diagnosed PH and in 83 healthy children. 26227630 2015
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE The present case-control study failed to show significant association of G894T variant with EH in northern Han Chinese. 24846690 2015
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Polymorphisms of rs1799983 (G>T) and rs1800780 (A>G) of the eNOS gene associated with susceptibility to essential hypertension in the Chinese Hui ethnic population. 23613274 2013
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE In this study, we investigated the association of three clinically relevant polymorphisms (promoter T786C, intronic 4a/b, and nonsynonymous G894T) in a case-control sample of 230 ethnically homogeneous (Caucasians) patients with essential hypertension, with (n = 64) and without (n = 166) clinically diagnosed LVH.Haplotype analysis was also performed. 20482221 2010
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Here, we investigated the role of the -922A/G, -786T/C, 4b/4a, and 894G/T polymorphisms of the NOS3 and NO(x) levels in 800 consecutive unrelated subjects comprising 455 patients of essential hypertension and 345 controls. 18325347 2008
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Association of eNOS Glu298Asp gene polymorphism with essential hypertension in Asian Indians. 17935708 2008
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE The present study suggested an association between a G894T polymorphism of eNOS gene and EH in Hani and Yi minority groups of China. 18164968 2008
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Gender specific association of endothelial nitric oxide synthase gene (Glu298Asp) polymorphism with essential hypertension in a south Indian population. 18582449 2008
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE In conclusion, the present study in a population of Pakistani adult Pathans does not support the association of the eNOS gene G894T polymorphism to essential hypertension. 16765468 2007
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Up to now, there has been conflicting data regarding the association between three clinically relevant polymorphisms (T-786C, intron4b/a and G894T) of the eNOS gene and essential hypertension. 16834924 2006
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Associations of the angiotensin II type 1 receptor A1166C and the endothelial NO synthase G894T gene polymorphisms with silent subcortical white matter lesions in essential hypertension. 16109907 2005
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Evidence for the involvement of eNOS single nucleotide polymorphisms in the development of essential hypertension is limited, though the eNOS Glu298Asp polymorphism appears to influence the blood pressure response to exercise. 12530931 2003
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Indeed, a missense mutation in the endothelial NO gene caused by a Glu298Asp alteration has been strongly associated with essential hypertension, coronary artery spasm, and myocardial infarction. 11967250 2002
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE The Glu298Asp polymorphism may contribute to the complex pathogenesis of essential hypertension and may be a factor in the resistance of these patients to conventional antihypertensive therapy. 11394896 2001
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Given the evidence of positive association of another polymorphism in the eNOS gene, the Glu298Asp polymorphism, with essential hypertension, special attention will be required to interpret the results of a case-control study for genetic risk factors. 11131266 2000
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE Significant association between a Glu298Asp polymorphism of the endothelial nitric oxide synthase (eNOS) gene and essential hypertension was recently reported in Japanese populations, with the 298Asp variant showing a higher prevalence in hypertensive patients (10.3% to 12.0%) than in normotensive subjects (5.0% to 5.8%). 10205226 1999
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.100 GeneticVariation BEFREE In conclusion, the Glu298Asp missense variant was significantly associated with essential hypertension, which suggests that it is a genetic susceptibility factor for essential hypertension. 9674630 1998